[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ivan et al., 2016 - Google Patents

Bifunctional ligands for inhibition of tight-binding protein–protein interactions

Ivan et al., 2016

View PDF
Document ID
15478425390849691404
Author
Ivan T
Enkvist E
Viira B
Manoharan G
Raidaru G
Pflug A
Alam K
Zaccolo M
Engh R
Uri A
Publication year
Publication venue
Bioconjugate Chemistry

External Links

Snippet

The acknowledged potential of small-molecule therapeutics targeting disease-related protein–protein interactions (PPIs) has promoted active research in this field. The strategy of using small molecule inhibitors (SMIs) to fight strong (tight-binding) PPIs tends to fall short …
Continue reading at ora.ox.ac.uk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Similar Documents

Publication Publication Date Title
Ni et al. Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
Fadeyi et al. Covalent enzyme inhibition through fluorosulfate modification of a noncatalytic serine residue
Eggert et al. Discovery and characterization of a highly potent and selective aminopyrazoline-based in vivo probe (BAY-598) for the protein lysine methyltransferase SMYD2
Lu et al. Harnessing allostery: a novel approach to drug discovery
Meng et al. Tyrosine kinase activation and conformational flexibility: lessons from Src-family tyrosine kinases
Scott et al. Fragment-based approaches in drug discovery and chemical biology
Johnson et al. Dynamics of cAMP-dependent protein kinase
Ivan et al. Bifunctional ligands for inhibition of tight-binding protein–protein interactions
Mesrouze et al. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD
Breitenlechner et al. Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants
Feng et al. K-RasG12D has a potential allosteric small molecule binding site
Hammoudeh et al. Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase
Deng et al. Molecular basis for N-terminal alpha-synuclein acetylation by human NatB
Rahm et al. Creation of a novel class of potent and selective MutT homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design
Lavogina et al. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases
Preuss et al. Nucleotide binding, evolutionary insights, and interaction partners of the pseudokinase Unc-51-like kinase 4
AU2009273465A1 (en) Fluorescently or spin-labeled kinases for rapid screening and identification of novel kinase inhibitor scaffolds
Czapinska et al. Halogen Atoms in the Protein–Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2
Arencibia et al. An allosteric inhibitor scaffold targeting the PIF-pocket of atypical protein kinase C isoforms
Andreev et al. Addressing a trapped high-energy water: design and synthesis of highly potent pyrimidoindole-based glycogen synthase kinase-3β inhibitors
Engelberg et al. Discovery of an H3K36me3-derived peptidomimetic ligand with enhanced affinity for plant homeodomain finger protein 1 (PHF1)
Pedley et al. Flexibility of PCNA-protein interface accommodates differential binding partners
Serafim et al. Discovery of a potent dual SLK/STK10 inhibitor based on a maleimide scaffold
Zhang et al. Legionella metaeffector MavL reverses ubiquitin ADP-ribosylation via a conserved arginine-specific macrodomain
Mingione et al. Validation of an allosteric binding site of Src kinase identified by unbiased ligand binding simulations